Oncoinvent
Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.
About Oncoinvent
Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
Company Facts
- Headquarters
- Oslo
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- m_and_a
- Total Funding
- $71,962,950
- Last Funding Type
- undisclosed
- Last Funding Date
- 2024-12-04
- Website
- oncoinvent.com
Industries & Categories
Biotechnology, Chemical, Life Science
Social Links
Canonical: https://fsome.com/organization/oncoinvent-582 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.